Latest / CareTalk: Healthcare. Unfiltered.
The Cost Crisis of Weight Loss Drugs
Send us Fan Mail
GLP-1 medications like Novo Nordisk's Wegovy and Ozempic are taking the market by storm.
With demand soaring, many patients are realizing these medications are either not being covered or simply too expensive.
Is this all due to provider greed or is the issue more complicated?
In this episode of CareTalk, David E. Williams and John Driscoll discuss how the growing demand for weight-loss drugs is creating a conundrum for providers, forcing them to decide between avoiding the costs associated with at-risk patients or investing upfront for long-term savings.
This episode is…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.